## MMC: Marsh & McLennan Companies, Inc - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -2.9% below STRENGTH zone (4.0-10.0%); PEG 2.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($175.19)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Cyber Budgets to Get Hot: Can Marsh & McLennan Take the Advisory Lead?**
- Source: TradingView | 20251210T160756 | Somewhat-Bullish | Relevance: 98%
- A new global cybersecurity report by Marsh, a Marsh & McLennan Companies arm, reveals that while many organizations are confident in their cyber-risk management, 70% experienced a major third-party incident in the last year, prompting 66% to plan increased cybersecurity investments. This shift positions Marsh & McLennan (MMC) to capitalize on rising demand for cybersecurity risk management, potentially boosting revenue in its advisory and insurance brokerage lines. MMC, currently holding a Zacks Rank #3 (Hold), shows strong revenue and EPS growth expectations for 2025 and 2026.

**2. Ossiam Has $4.02 Million Stock Position in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251209T124545 | Neutral | Relevance: 98%
-  Ossiam significantly increased its stake in Marsh & McLennan Companies by 75.8% in Q2, boosting its holdings to 18,378 shares valued at approximately $4.02 million. Meanwhile, CEO John Q. Doyle sold over 21,000 shares for $3.84 million, reducing his insider position. The company reported strong Q3 earnings, beating analyst expectations, and maintains a "Hold" consensus rating with a $223 average target price.

**3. Natixis Lowers Holdings in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251209T123545 | Neutral | Relevance: 98%
-  Natixis significantly reduced its stake in Marsh & McLennan Companies by 37.4% in the second quarter, selling over 36,000 shares. This comes amidst other institutional investor activity and various analyst price target adjustments, though the consensus rating remains "Hold." Meanwhile, CEO John Q. Doyle also sold a portion of his shares, reducing his position by nearly 20%.

**4. Axa S.A. Sells 7,842 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251210T090845 | Neutral | Relevance: 98%
- Axa S.A. has reduced its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC) by 4.0% in the second quarter, selling 7,842 shares and now owning 189,785 shares valued at $41,495,000. Other institutional investors have also adjusted their positions in MMC, while company CEO John Q. Doyle recently sold 21,079 shares. Analysts have issued varied ratings for MMC, with an average "Hold" rating and a price target of $223.00, following recent earnings that beat consensus estimates.

**5. Temasek Holdings Private Ltd Buys Shares of 143,356 Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251208T124728 | Somewhat-Bullish | Relevance: 98%
-  Temasek Holdings Private Ltd acquired a new stake of 143,356 shares in Marsh & McLennan Companies, Inc. (NYSE:MMC) during the second quarter, valued at approximately $31.343 million. Other institutional investors also adjusted their holdings in MMC. The company recently declared a quarterly dividend of $0.90 per share and reported strong earnings, exceeding analysts' consensus estimates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $201 | $211 | -5% |
| 2025-11-20 | Barclays | $206 | $221 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-11-20 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 14.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.00 elevated, pricing in significant growth expectations. Forward P/E 17.5x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $88.9B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.00 |
| Forward P/E | 17.5 |
| Current P/E | 18.8 |
| YoY Growth | 7.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.1% to -2.9% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.88% (CS: 33) | Weak |
| RSI_14 | 43.6 | Neutral |
| MACD Histogram | 0.38 | Bullish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.858x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $180.93
- **Stop Loss:** $175.19 (3.2% risk)
- **Target:** $186.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 174
- **Position Value:** $31,481.82
- **Portfolio %:** 31.48%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*